| アブストラクト | BACKGROUND: Although dual antiplatelet therapy (DAPT) prevents early recurrence of non-cardioembolic stroke, data on prasugrel-based DAPT are limited. We aimed to compare the effectiveness and safety of prasugrel- and clopidogrel-based DAPTs in acute atherothrombotic stroke. METHODS: Using the Diagnosis Procedure Combination database from April 2020 to March 2023, we identified patients admitted with atherothrombotic stroke who received aspirin plus clopidogrel or prasugrel. We compared a favorable functional outcome at discharge, hemorrhagic complications, seven-day mortality, and readmission for atherothrombotic stroke recurrence between the groups using propensity score overlap-weighting analyses. The number needed to treat (NNT) and harm (NNH) was calculated for each effectiveness and safety measure, respectively. RESULTS: Among 48,863 eligible patients (46,153 receiving clopidogrel and 2710 receiving prasugrel), the proportion of patients with a favorable functional outcome at discharge was higher in the prasugrel-based DAPT group (41.4 % vs. 40.0 %; adjusted risk difference [aRD], 1.4 %; 95 % confidence interval [CI], 0.4 %-2.4 %), corresponding to an NNT of 71. Overall hemorrhagic complications were more frequent in the prasugrel-based DAPT group (3.9 % vs. 2.4 %; aRD, 1.4 %; 95 % CI, 1.1 %-1.8 %), with an NNH of 67. No significant difference was observed in the seven-day mortality (0.50 % vs. 0.43 %; aRD, 0.07 %; 95 % CI, -0.06 %-0.21 %) or the proportion of 90-day readmissions for atherothrombotic stroke recurrence (0.91 % and 1.08 %; aRD, -0.17 %; 95 % CI, -0.37 %-0.03 %). CONCLUSIONS: Prasugrel-based DAPT may improve outcomes without increasing early mortality, however, bleeding risk warrants caution. Careful patient selection is crucial for balancing ischemic benefits and bleeding risks, aiding acute-phase treatment decisions for high-risk patients. |
|---|
| ジャーナル名 | Journal of the neurological sciences |
|---|
| Pubmed追加日 | 2025/12/20 |
|---|
| 投稿者 | Nakashima, Saki; Aso, Shotaro; Yasunaga, Hideo; Sato, Kenichiro; Niimi, Yoshiki; Isogai, Toshiaki; Matsui, Hiroki; Fushimi, Kiyohide; Toda, Tatsushi; Kodama, Satoshi |
|---|
| 組織名 | Department of Neurology, Graduate School of Medicine, The University of Tokyo,;Tokyo, Japan.;Department of Health Services Research, Graduate School of Medicine, The;University of Tokyo, Tokyo, Japan.;Department of Clinical Epidemiology and Health Economics, School of Public;Health, The University of Tokyo, Tokyo, Japan.;Unit for Early and Exploratory Development, The University of Tokyo Hospital,;Tokyo, Japan; Dementia Inclusion and Therapeutics, The University of Tokyo;Hospital, Tokyo, Japan.;University of Tokyo, Tokyo, Japan; Department of Cardiology, Tokyo Metropolitan;Tama Medical Center, Tokyo, Japan.;Department of Health Policy and Informatics, Institute of Science Tokyo Graduate;School, Tokyo, Japan.;Department of Neurology, The University of Iowa Hospitals and Clinics, Iowa,;United States. Electronic address: satoshi-kodama@uiowa.edu. |
|---|
| Pubmed リンク | https://www.ncbi.nlm.nih.gov/pubmed/41418527/ |
|---|
